Back to Search
Start Over
European collaboration on relative effectiveness assessments:What is needed to be successful?
- Source :
- Kleijnen, S, Toenders, W, de Groot, F, Huic, M, George, E, Wieseler, B, Pavlovic, M, Bucsics, A, Siviero, P D, van der Graaff, M, Rdzany, R, Kristensen, F B & Goettsch, W 2015, ' European collaboration on relative effectiveness assessments : What is needed to be successful? ', Health Policy, vol. 119, no. 5, pp. 569-576 . https://doi.org/10.1016/j.healthpol.2015.01.018
- Publication Year :
- 2015
-
Abstract
- Objective: The objective of this study is to identify the possible barriers and critical success factors for the implementation of European collaboration in the field of relative effectiveness assessment (REA) of drugs. Methods: Data were gathered through semi-structured interviews with representatives from eight European health technology assessment (HTA) organisations involved in assessment of drugs for coverage decision-making (AAZ, AIFA, AHTAPol, HAS, HVB, IQWIG, NICE and ZiN). Results: Potential barriers identified mainly relate to methodology, resources and challenges with implementation in the respective national processes (e.g. legal restrictions). The most critical success factors for production of cross-border assessments were the continuous cooperation of competent partners, and the quality and timely availability of the assessment. Conclusion: Further adaptation of the process and methods is required for optimal collaboration. In the near future it can be expected that cross-border assessments will meet in particular the needs of smaller/middle-sized European countries and also European countries with less developed HTA systems as the potential efficiency/quality gains are the highest for these countries. Therefore, national implementation of cross-border assessments is especially likely in these countries in the coming years. Once more experience is gained with cross-border assessments, and successes become more evident, efficiency/quality gains may also be likely for some larger countries with well established processes.
- Subjects :
- Comparative Effectiveness Research
Process management
Process (engineering)
International Cooperation
media_common.quotation_subject
Nice
European collaboration
Surveys and Questionnaires
Prohibitins
Critical success factor
Relative effectiveness
Humans
Production (economics)
Medicine
Quality (business)
Health technology assessment
Qualitative Research
Reimbursement
computer.programming_language
media_common
Relative effectiveness Relative effectiveness assessment PharmaceuticalsHealth technology assessment European collaboration Reimbursement
Actuarial science
business.industry
Health Policy
Health technology
Europe
Cross-Sectional Studies
Pharmaceutical Preparations
Relative effectiveness assessment
Models, Organizational
Drug Evaluation
Pharmaceuticals
business
computer
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Kleijnen, S, Toenders, W, de Groot, F, Huic, M, George, E, Wieseler, B, Pavlovic, M, Bucsics, A, Siviero, P D, van der Graaff, M, Rdzany, R, Kristensen, F B & Goettsch, W 2015, ' European collaboration on relative effectiveness assessments : What is needed to be successful? ', Health Policy, vol. 119, no. 5, pp. 569-576 . https://doi.org/10.1016/j.healthpol.2015.01.018
- Accession number :
- edsair.doi.dedup.....8b71c1a29a24d530f90caba4fb90be4f